Visceral Adiposity Index
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function. RESEARCH DESIGN AND METHODS: Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors. RESULTS: All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52–3.95; P < 0.001) and cerebrovascular (1.63; 1.06–2.50; P = 0.025) events. VAI also showed significant inverse correlation with insulin sensitivity during euglycemic-hyperinsulinemic clamp in a subgroup of patients (Rs = −0.721; P < 0.001). By contrast, no correlations were found for waist circumference and BMI. CONCLUSIONS: Our study suggests VAI is a valuable indicator of “visceral adipose function” and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increased fat mass is associated with elevated adipocytokine and proinflammatory cytokines, insulin resistance, increased risk of developing adverse outcomes of diabetes, hypertriglyceridemia, hypercholesterolemia, hypertension, atherosclerosis, and a higher mortality rate [10].”
From Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study (2019) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pouliot, M.-C., Després, J.-P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,085
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
Unger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677 · cited 1×
“Indeed, this condition characterized by visceral obesity and “high-triglyceride/low–HDL cholesterol dyslipidemia” has been associated with physiological age-linked leptin resistance, muscle, and liver insulin resistance, lipotoxic cardiomyopathy, and generalized endothelial dysfunction (15).”
BackgroundIs visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608 · cited 1×
“V isceral obesity (1) is associated with increased adipocytokine production, proinflammatory activity (2), deterioration of insulin sensitivity (3), increased risk of developing diabetes, “high-triglyceride/low–HDL cholesterol dyslipidemia,” hypertension, atherosclerosis, and higher mortality rate (4–7).”
BackgroundSubdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538
Body fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
Taksali, S. E., Caprio, S., Dziura, J., Dufour, S., Calí, A. M. G., Goodman, T. R., Papademetris, X., Burgert, T. S., Pierpont, B. M., Savoye, M., et al. (2008) · Diabetes · doi:10.2337/db07-0932 · Cited by 353
Rader, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.003 · Cited by 346
Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function
Sironi, A. M., Gastaldelli, A., Mari, A., Ciociaro, D., Postano, V., Buzzigoli, E., Ghione, S., Turchi, S., Lombardi, M., & Ferrannini, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000137982.10191.0a · Cited by 268
Research works printed but not linked: 1
- De Fronzo, 1979, The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin, Am J Physiol, 237, 214
Cited by
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Piché, M.-E., Tchernof, A., & Després, J.-P. (2020) · Circulation Research · doi:10.1161/circresaha.120.316101 · Cited by 1,986
Body Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481
Er, L.-K., Wu, S., Chou, H.-H., Hsu, L.-A., Teng, M.-S., Sun, Y.-C., & Ko, Y.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149731 · Cited by 708
“The visceral adiposity index (VAI), a mathematical model used to identify IR, is based on the anthropometric body mass index (BMI), waist circumference (WC), and metabolic (TG and HDL-C) parameters [9,10].”
BackgroundMethodDu, T., Yuan, G., Zhang, M., Zhou, X., Sun, X., & Yu, X. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-1207347889137599 · Cited by 620
Fedchuk, L., Nascimbeni, F., Pais, R., Charlotte, F., Housset, C., Ratziu, V., & the LIDO Study Group (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12963 · Cited by 500
Lim, J., Kim, J., Koo, S. H., & Kwon, G. C. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212963 · Cited by 464
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Inzucchi, S. E., Zinman, B., Wanner, C., Ferrari, R., Fitchett, D., Hantel, S., Espadero, R.-M., Woerle, H.-J., Broedl, U. C., & Johansen, O. E. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114559852 · Cited by 399
Metabolic Syndrome Pathophysiology and Predisposing Factors
Bovolini, A., Garcia, J., Andrade, M. A., & Duarte, J. A. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1263-0898 · Cited by 385
“On the other hand, central fat deposition has been recognized as highly damaging metabolically and continuously associated with IR [38] and cardiovascular diseases [39].”
BackgroundRico‐Martín, S., Calderón‐García, J. F., Sánchez‐Rey, P., Franco‐Antonio, C., Martínez Alvarez, M., & Sánchez Muñoz‐Torrero, J. F. (2020) · Obesity Reviews · doi:10.1111/obr.13023 · Cited by 355
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
Amato, M. C., & Giordano, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/730827 · Cited by 350
“…University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy Correspondence should be addressed to Marco Calogero Amato; marcoamato7@gmail.com Received 12 December 2013; Accepted 29 March 2014; Published 14 April 2014 Academic Editor: Yi-Hao Yu Copyright © 2014 M. C. Amato and C. Giordano.”
BackgroundSelf-citationda Silva, A., Caldas, A. P. S., Hermsdorff, H. H. M., Bersch-Ferreira, Â. C., Torreglosa, C. R., Weber, B., & Bressan, J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0893-2 · Cited by 299
A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese
Xia, M.-F., Chen, Y., Lin, H.-D., Ma, H., Li, X.-M., Aleteng, Q., Li, Q., Wang, D., Hu, Y., Pan, B.-S., et al. (2016) · Scientific Reports · doi:10.1038/srep38214 · Cited by 292
Hu, L., Huang, X., You, C., Li, J., Hong, K., Li, P., Wu, Y., Wu, Q., Wang, Z., Gao, R., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183934 · Cited by 271
Amato, M. C., Giordano, C., Pitrone, M., & Galluzzo, A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-183 · Cited by 263
Self-citationAdiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation
Frühbeck, G., Catalán, V., Rodríguez, A., Ramírez, B., Becerril, S., Salvador, J., Colina, I., & Gómez-Ambrosi, J. (2019) · Nutrients · doi:10.3390/nu11020454 · Cited by 262
“The marker of dysfunctional adipose tissue VAI was calculated as previously established [31].”
Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Barrea, L., Annunziata, G., Muscogiuri, G., Di Somma, C., Laudisio, D., Maisto, M., De Alteriis, G., Tenore, G. C., Colao, A., & Savastano, S. (2018) · Nutrients · doi:10.3390/nu10121971 · Cited by 257
“VAI is a surrogate of adipocyte dysfunction independently correlated with insulin sensitivity, and cardio-metabolic risk in primary-care non-obese subjects [20].”
BackgroundInfluentialMeasuring and estimating insulin resistance in clinical and research settings
Gastaldelli, A. (2022) · Obesity · doi:10.1002/oby.23503 · Cited by 244
Younes, R., & Bugianesi, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1677517 · Cited by 235
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Paschou, S. A., Polyzos, S. A., Anagnostis, P., Goulis, D. G., Kanaka-Gantenbein, C., Lambrinoudaki, I., Georgopoulos, N. A., & Vryonidou, A. (2020) · Endocrine · doi:10.1007/s12020-019-02085-7 · Cited by 231
Ahn, N., Baumeister, S. E., Amann, U., Rathmann, W., Peters, A., Huth, C., Thorand, B., & Meisinger, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-46187-8 · Cited by 230
Excess body weight: Novel insights into its roles in obesity comorbidities
Zhang, X., Ha, S., Lau, H. C.-H., & Yu, J. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.03.008 · Cited by 228
Feng, R.-N., Du, S.-S., Wang, C., Li, Y.-C., Liu, L.-Y., Guo, F.-C., & Sun, C.-H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17932 · Cited by 226
Wei, J., Liu, X., Xue, H., Wang, Y., & Shi, Z. (2019) · Nutrients · doi:10.3390/nu11071580 · Cited by 212
“The VAI, which is comprised of anthropometric measures like BMI, WC and clinical measures of serum triglycerides (TG) and high-density lipoprotein-cholesterol (HDL-C) levels, was shown to be a better surrogate index than these single anthropometric indices in predicting insulin resistant-related metabolic disorders [1…”
BackgroundZheng, S., Shi, S., Ren, X., Han, T., Li, Y., Chen, Y., Liu, W., Hou, P. C., & Hu, Y. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1020-8 · Cited by 203
“VAI and TyG were calculated using the former formula [10].”
MethodJeanes, Y. M., & Reeves, S. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000287 · Cited by 194
Mazidi, M., Kengne, A.-P., Katsiki, N., Mikhailidis, D. P., & Banach, M. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.10.007 · Cited by 192
Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study
Kouli, G.-M., Panagiotakos, D. B., Kyrou, I., Georgousopoulou, E. N., Chrysohoou, C., Tsigos, C., Tousoulis, D., & Pitsavos, C. (2017) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.06.015 · Cited by 190
Bello-Chavolla, O. Y., Antonio-Villa, N. E., Vargas-Vázquez, A., Viveros-Ruiz, T. L., Almeda-Valdes, P., Gomez-Velasco, D., Mehta, R., Elias-López, D., Cruz-Bautista, I., Roldán-Valadez, E., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.07.012 · Cited by 181
Neck circumference as an independent predictive contributor to cardio-metabolic syndrome
Zhou, J.-Y., Ge, H., Zhu, M.-F., Wang, L.-J., Chen, L., Tan, Y.-Z., Chen, Y.-M., & Zhu, H.-L. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-76 · Cited by 180
Roriz, A. K. C., Passos, L. C. S., de Oliveira, C. C., Eickemberg, M., Moreira, P. D. A., & Sampaio, L. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103499 · Cited by 180
What lipodystrophies teach us about the metabolic syndrome
Mann, J. P., & Savage, D. B. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129190 · Cited by 179
Lee, J., Kim, B., Kim, W., Ahn, C., Choi, H. Y., Kim, J. G., Kim, J., Shin, H., Kang, J. G., & Moon, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82053-2 · Cited by 177
Knowles, K. M., Paiva, L. L., Sanchez, S. E., Revilla, L., Lopez, T., Yasuda, M. B., Yanez, N. D., Gelaye, B., & Williams, M. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/931402 · Cited by 176
Qiao, T., Luo, T., Pei, H., Yimingniyazi, B., Aili, D., Aimudula, A., Zhao, H., Zhang, H., Dai, J., & Wang, D. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01670-x · Cited by 175
Nussbaumerova, B., & Rosolova, H. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01167-2 · Cited by 173
ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population
Wang, J., Xu, C., Xun, Y., Lu, Z., Shi, J., Yu, C., & Li, Y. (2015) · Scientific Reports · doi:10.1038/srep16494 · Cited by 173
Double diabetes—when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition
Bielka, W., Przezak, A., Molęda, P., Pius‐Sadowska, E., & Machaliński, B. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02145-x · Cited by 172
Stȩpień, M., Stępień, A., Wlazeł, R. N., Paradowski, M. T., Banach, M., & Rysz, J. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-29 · Cited by 170
“On the other hand, higher values of BMI, WHtR and BAI may be indicators of CVR, as was previously reported [20-28,33,35].”
Neeland, I. J., McGuire, D. K., Chilton, R., Crowe, S., Lund, S. S., Woerle, H. J., Broedl, U. C., & Johansen, O. E. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115616901 · Cited by 168
Body composition assessment for the definition of cardiometabolic risk.
Amato, M. C., Guarnotta, V., & Giordano, C. S. D. S. (2013) · PubMed · doi:10.3275/8943 · Cited by 164
Self-citationThe pathophysiology of visceral adipose tissues in cardiometabolic diseases
Lee, M., & Kim, J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116116 · Cited by 161
Li, X., Sun, M., Yang, Y., Yao, N., Yan, S., Wang, L., Hu, W., Guo, R., Wang, Y., & Li, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.862919 · Cited by 160
“WithWC in centimeters, BMI in kilograms per square meter, TG and HDL-C both in millimoles per liter (20).”
BackgroundWang, H., Liu, A., Zhao, T., Gong, X., Pang, T., Zhou, Y., Xiao, Y., Yan, Y., Fan, C., Teng, W., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016062 · Cited by 159
Bala, C. G., Fronea, O. F. G., Pop, D., Pop, C., Caloian, B., Comşa, H., Bozan, C., Matei, C., & Dorobanţu, M. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0122 · Cited by 159
SELVI, N. M. K., NANDHINI, S., SAKTHIVADIVEL, V., LOKESH, S., SRINIVASAN, A. R., & SUMATHI, S. (2021) · Maedica - A Journal of Clinical Medicine · doi:10.26574/maedica.2021.16.3.375 · Cited by 158
Tétreault, L.-F., Perron, S., & Smargiassi, A. (2013) · International Journal of Public Health · doi:10.1007/s00038-013-0489-7 · Cited by 158
Amato, M. C., Pizzolanti, G., Torregrossa, V., Misiano, G., Milano, S., & Giordano, C. S. D. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091969 · Cited by 157
Self-citationFlehmig, G., Scholz, M. R., Klöting, N., Faßhauer, M., Tönjes, A., Stümvoll, M., Youn, B., & Blüher, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099785 · Cited by 156
“Fat distribution, specifically visceral obesity may represent such an underlying factor [53].”
BackgroundCicero, A. F. G., Fogacci, F., Bove, M., Giovannini, M., & Borghi, C. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02271-8 · Cited by 155
Oh, J., Sung, Y., & Lee, H. J. (2013) · Obesity · doi:10.1002/oby.20096 · Cited by 154
Obese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile
Succurro, E., Segura‐Garcìa, C., Ruffo, M., Caroleo, M., Rania, M., Aloi, M., Fazio, P. D., Sesti, G., & Arturi, F. (2015) · Medicine · doi:10.1097/md.0000000000002098 · Cited by 147
“Moreover, among BED obese, we found an increased abdominal circumference, an indirect index of visceral adiposity and an increased VAI, an indicator of a dysfunction of adipose tissue.(21,31,32) In obese patients, visceral adipose tissue accumulation has been associated with an increased production of free fatty acids…”
Petta, S., Amato, M. C., Marco, V. D., Cammà, C., Pizzolanti, G., Barcellona, M. R., Cabibi, D., Galluzzo, A., Sinagra, D., Giordano, C. S. D. S., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04929.x · Cited by 146
Self-citationBorruel, S., Moltó, J. F., Alpañés, M., Fernández‐Durán, E., Álvarez‐Blasco, F., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114112 · Cited by 144
Gelli, C., Tarocchi, M., Abenavoli, L., Renzo, L. D., Galli, A., & LORENZO, A. D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i17.3150 · Cited by 142
Wu, K., Kuo, P., Su, S., Chen, Y., Yeh, M.-L., Huang, C., Yang, J., Lin, C.-I., Hsieh, M., Hsieh, M., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.12.026 · Cited by 140
Qin, Z., Chang, K., Yang, Q., Yu, Q., Liao, R., & Su, B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.941926 · Cited by 140
Metabolic effects of prolactin
Pirchio, R., Graziadio, C., Colao, A., Pivonello, R., & Auriemma, R. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1015520 · Cited by 139
“Visceral adiposity index, a surrogate parameter of adipose tissue dysfunction associated with cardiometabolic risk in healthy subjects, significantly decreased after CAB long-term therapy in hyperprolactinemic patients (100), particularly using doses higher than 0.”
BackgroundFiorentino, T. V., Marini, M. A., Succurro, E., Andreozzi, F., & Sesti, G. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000911 · Cited by 133
Li, Y., Gui, J., Liu, H., Guo, L., Li, J., Lei, Y., Li, X., Sun, L., Yang, L., Yuan, T., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1201132 · Cited by 129
Peng, H., Pan, L., Ran, S., Wang, M., Huang, S., Zhao, M., Cao, Z., Yao, Z., Xu, L., Yang, Q., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083032 · Cited by 127
Musso, G., Cassader, M., De Michieli, F., Rosina, F., Orlandi, F., & Gambino, R. (2012) · Hepatology · doi:10.1002/hep.25739 · Cited by 126
Ramírez‐Vélez, R., Correa‐Bautista, J. E., Tordecilla‐Sanders, A., Ojeda-Pardo, M. L., Cobo-Mejía, E. A., Castellanos-Vega, R. D. P., García‐Hermoso, A., González‐Jiménez, E., Schmidt‐RioValle, J., & González‐Ruíz, K. (2017) · Nutrients · doi:10.3390/nu9091009 · Cited by 125
Ramírez‐Vélez, R., Pérez-Sousa, M. Á., González‐Ruíz, K., Cano, C. A., Schmidt‐RioValle, J., Correa‐Rodríguez, M., Izquierdo, M., Romero-García, J. A., Rodríguez, A. Y. C., Triana-Reina, H. R., et al. (2019) · Nutrients · doi:10.3390/nu11112654 · Cited by 124
“Perhaps the disagreement in these studies on the ability of anthropometric indicators to predict prediabetes is the result of the ethnic origins of the populations used in these different studies [11,12,16,17].”
ResultGui, J., Li, Y., Liu, H., Guo, L., Li, J., Lei, Y., Li, X., Sun, L., Liu, Y., Yuan, T., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1073824 · Cited by 124
Wu, J., Gong, L., Li, Q., Hu, J., Zhang, S., Wang, Y., Huang, Z., Yang, S., & Wang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-14251-w · Cited by 123
Petta, S., Amato, M. C., Cabibi, D., Cammà, C., Marco, V. D., Giordano, C. S. D. S., Galluzzo, A., & Craxì, A. (2010) · Hepatology · doi:10.1002/hep.23859 · Cited by 119
Self-citationEffects of Polyphenols on Thermogenesis and Mitochondrial Biogenesis
dos Santos, T. W., Pereira, Q. C., Teixeira, L., Gambero, A., Villena, J. A., & Ribeiro, M. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092757 · Cited by 117
Oxidative Stress in Association with Metabolic Health and Obesity in Young Adults
Jakubiak, G. K., Osadnik, K., Lejawa, M., Kasperczyk, S., Osadnik, T., & Pawlas, N. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9987352 · Cited by 115
Metabolic Obesity in People with Normal Body Weight (MONW)—Review of Diagnostic Criteria
Pluta, W. W., Dudzińska, W., & Lubkowska, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020624 · Cited by 113
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alsayegh, A. A., Hakami, Z. H., Khamjan, N. A., Saad, H. M., Batiha, G. E., & WAARD, M. M. D. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03817-4 · Cited by 113
Bozorgmanesh, M., Hadaegh, F., Khalili, D., & Prof, A. F. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-20 · Cited by 113
Bozorgmanesh, M., Hadaegh, F., & Azizi, F. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-88 · Cited by 112
Ciresi, A., Amato, M. C., Guarnotta, V., Castro, F. L., & Giordano, C. S. D. S. (2013) · Clinical Endocrinology · doi:10.1111/cen.12204 · Cited by 111
Self-citationHan, M., Qin, P., Li, Q., Qie, R., Liu, L., Zhao, Y., Liu, D., Zhang, D., Guo, C., Zhou, Q., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3370 · Cited by 111
Effect of Cabergoline on Metabolism in Prolactinomas
Auriemma, R. S., Granieri, L., Galdiero, M., Simeoli, C., Perone, Y., Vitale, P., Pivonello, C., Negri, M., Mannarino, T., Giordano, C. S. D. S., et al. (2013) · Neuroendocrinology · doi:10.1159/000357810 · Cited by 109
Self-citationDu, T., Yu, X., Zhang, J., & Sun, X. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0715-2 · Cited by 109
Stefanescu, A., Revilla, L., Lopez, T., Sanchez, S. E., Williams, M. A., & Gelaye, B. (2020) · Journal of International Medical Research · doi:10.1177/0300060519848854 · Cited by 106
“These include measures such as body mass index (BMI) and waist circumference (WC), which have been used in clinical practice for decades, as well as novel measures such as the Body Roundness Index (BRI),(3) A Body Shape Index (ABSI)(4) and the Visceral Adiposity Index (VAI).(5) Previous study findings on the associati…”
Lazzer, S., D’Alleva, M., Isola, M., Martino, M. D., Caroli, D., Bondesan, A., Marra, A., & Sartório, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093055 · Cited by 104
“Therefore, other predictive indexes for MetS have been developed: the visceral adiposity index (VAI) [14], which is based on two anthropometric parameters (waist circumference, WC, and BMI) and two biochemical factors (triglyceride, TG, and high-density lipoprotein, HDL) and the cardiometabolic index (CMI) which integ…”
BackgroundZhang, Z., Zhao, L. Y., Lu, Y., Meng, X., & Zhou, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04309-x · Cited by 104
Salazar, M. R., Carbajal, H. A., Espeche, W. G., Aizpurúa, M., Maciel, P. M., & Reaven, G. M. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.10.012 · Cited by 104
He, H., Xie, Y., Chen, Q., Li, Y., Li, X.-X., Mu, Y.-K., Duo, X., Gao, Y., & Zheng, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02396-8 · Cited by 102
Amato, M. C., Verghi, M., Galluzzo, A., & Giordano, C. S. D. S. (2011) · Human Reproduction · doi:10.1093/humrep/der088 · Cited by 101
Self-citationClinical surrogate markers for predicting metabolic syndrome in middle‐aged and elderly Chinese
Li, R., Li, Q., Cui, M., Yin, Z., Li, L., Zhong, T., Huo, Y., & Xie, P. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12708 · Cited by 100
Barrea, L., Muscogiuri, G., Pugliese, G., de Alteriis, G., Colao, A., & Savastano, S. (2021) · Nutrients · doi:10.3390/nu13113925 · Cited by 99
“In particular, VAI is an index based on a combination of anthropometric and metabolic parameters that is highly correlated with visceral adiposity measured by magnetic resonance imaging and expression of dysfunctional adipocytes [62].”
BackgroundDu, T., Sun, X., Huo, R., & Yu, X. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.181 · Cited by 98
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
Amato, M. C., Vesco, R., Vigneri, E., Ciresi, A., & Giordano, C. S. D. S. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0372-x · Cited by 98
Self-citationNovel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study
Brahimaj, A., Rivadeneira, F., Muka, T., Sijbrands, E. J. G., Franco, O. H., Dehghan, A., & Kavousi, M. (2019) · Diabetologia · doi:10.1007/s00125-019-4921-2 · Cited by 98
Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances
Al‐Daghri, N. M., Al-Attas, O. S., Alokail, M. S., Alkharfy, K. M., Charalampidis, P., Livadas, S., Κόλλιας, Α., Sabico, S., & Chrousos, G. P. (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12030 · Cited by 94
Nusrianto, R., Ayundini, G., Kristanti, M., Astrella, C., Amalina, N., Muhadi, M., Riyadina, W., Tahapary, D. L., & Soewondo, P. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107798 · Cited by 93
Barrea, L., Macchia, P. E., Tarantino, G., Somma, C. D., Pane, E., Balato, N., Napolitano, M., Colao, A., & Savastano, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0658-y · Cited by 92
Feng, R., Du, S., Chen, Y., Zheng, S., Zhang, W., Na, G., Li, Y., & Sun, C. (2015) · Scientific Reports · doi:10.1038/srep16919 · Cited by 92
Zhao, Q., Cheng, Y., Xu, Y.-K., Zhao, Z.-W., Liu, C., Sun, T., & Zhou, Y. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01383-7 · Cited by 91
Jiang, K., Luan, H., Pu, X., Wang, M., Yin, J., & Gong, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.921067 · Cited by 91
Xia, M., Lin, H., Chen, L., Wu, L., Ma, H., Li, Q., Aleteng, Q., Chen, Y., Sun, Y., Hu, Y., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3048 · Cited by 91
“A visceral adiposity index (VAI) based on clinically available metabolic parameters has been established in Italians,(10) and its use in Europeans and Saudi Arabians has shown a better prediction value than traditional clinical parameters for diabetes and cardiovascular diseases.(10,11) The prediction value of VAI for…”
MethodYang, J., Wang, F., Wang, J., Han, X., Hu, H., Yu, C., Yuan, J., Yao, P., Miao, X., Wei, S., et al. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0912-2 · Cited by 91
Zhang, D., Zhang, L., Yue, F., Zheng, Y., & Russell, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0589 · Cited by 90
Uruska, A. A., Zozulińska‐Ziółkiewicz, D., Niedźwiecki, P., Pietrzak, M., & Wierusz‐Wysocka, B. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.01.005 · Cited by 89
Guo, X., Zhang, S., Zhang, Q., Liu, L., Wu, H., Du, H., Shi, H., Wang, C., Xia, Y., Liu, X., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0176 · Cited by 89
Chen, C., Xu, Y. J., Guo, Z., Yang, J., Wu, M., & Hu, X. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-108 · Cited by 89
Metadata
- Authors
- Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group
- Affiliations
- University of Palermo (IT)
- Corresponding author
- Galluzzo, Aldo
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-12
- Volume
- 33
- Issue
- 4
- Pages
- 920-922
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2845052
- OpenAlex
- W2125944762
- Cited by
- 1,751
- References
- 14
- Citations by year
- 2026: 157 · 2025: 293 · 2024: 211 · 2023: 184 · 2022: 198 · 2021: 157 · 2020: 121 · 2019: 106 · 2018: 66 · 2017: 52 · 2016: 56 · 2015: 43 · 2014: 46 · 2013: 28 · 2012: 17
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- visceral adiposity index, visceral fat, waist circumference, body mass index, triglycerides, HDL cholesterol, metabolic syndrome, cardiovascular risk, cerebrovascular risk, insulin sensitivity, cardiometabolic risk
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Triglycerides, Body Mass Index, Logistic Models, Intra-Abdominal Fat, Waist Circumference, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.